Recruiting
Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia
NCT05366218
- Conditions
- ALL, Childhood B-Cell, Acute Lymphocytic Leukemia Refractory, Acute Lymphoid Leukemia Relapse, +4 more
- Locations
-
- Universitätsklinikum Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany
- University childrens Hospital Tübingen, Baden-Wurttemberg, Germany
- Klinik für Kinder- und Jugendmedizin Ulm, Baden-Wurttemberg, Germany
- Klinikum Dr. von Haunersches Kinderspital München, Bavaria, Germany